Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma By Ogkologos - March 3, 2025 665 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CEPHEUS study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Indications for Selpercatinib Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Safety and Antitumour Activity of Setidegrasib in Patients with Previously Treated Advanced KRAS p.G12D-mutated NSCLC and PADC MOST POPULAR Obesity and Alcohol Are Contributing to Increases in Bowel Cancer Rates... January 29, 2024 Managing Side Effects with South Asian Foods July 19, 2022 Reunión anual de la American Society of Clinical Oncology de 2022:... June 6, 2022 Cancer vaccines – where are we? February 24, 2023 Load more HOT NEWS Becoming My Own Advocate While Living With a Rare Cancer: A... ASCO20 Virtual Research Round Up Podcast: Central Nervous System Tumors and... Higher Pregnancy Rates and No Impact on Prognosis with Embryo/Oocyte Cryopreservation... FDA Grants Accelerated Approval to Tisotumab Vedotin-tftv for Recurrent or Metastatic...
